411 related articles for article (PubMed ID: 37581648)
21. Drug conjugate-based anticancer therapy - Current status and perspectives.
Yang Y; Wang S; Ma P; Jiang Y; Cheng K; Yu Y; Jiang N; Miao H; Tang Q; Liu F; Zha Y; Li N
Cancer Lett; 2023 Jan; 552():215969. PubMed ID: 36279982
[TBL] [Abstract][Full Text] [Related]
22. Cancer and Apoptosis.
Chaudhry GE; Akim AM; Sung YY; Muhammad TST
Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
[TBL] [Abstract][Full Text] [Related]
23. Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma.
Hilchie AL; Sharon AJ; Haney EF; Hoskin DW; Bally MB; Franco OL; Corcoran JA; Hancock REW
Biochim Biophys Acta; 2016 Dec; 1858(12):3195-3204. PubMed ID: 27693190
[TBL] [Abstract][Full Text] [Related]
24. Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions.
Nhàn NTT; Yamada T; Yamada KH
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629112
[TBL] [Abstract][Full Text] [Related]
25. Membrane disrupting lytic peptides for cancer treatments.
Leuschner C; Hansel W
Curr Pharm Des; 2004; 10(19):2299-310. PubMed ID: 15279610
[TBL] [Abstract][Full Text] [Related]
26. Peptide-Drug Conjugates: A New Hope for Cancer Management.
Chavda VP; Solanki HK; Davidson M; Apostolopoulos V; Bojarska J
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364057
[TBL] [Abstract][Full Text] [Related]
27. Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs).
Cooper BM; Iegre J; O' Donovan DH; Ölwegård Halvarsson M; Spring DR
Chem Soc Rev; 2021 Feb; 50(3):1480-1494. PubMed ID: 33346298
[TBL] [Abstract][Full Text] [Related]
28. The Potential Use of Anticancer Peptides (ACPs) in the Treatment of Hepatocellular Carcinoma.
Ng CX; Lee SH
Curr Cancer Drug Targets; 2020; 20(3):187-196. PubMed ID: 31713495
[TBL] [Abstract][Full Text] [Related]
29. Macromolecule-drug conjugates in targeted cancer chemotherapy.
Sezaki H; Hashida M
Crit Rev Ther Drug Carrier Syst; 1984; 1(1):1-38. PubMed ID: 6085861
[TBL] [Abstract][Full Text] [Related]
30. The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.
Davitt K; Babcock BD; Fenelus M; Poon CK; Sarkar A; Trivigno V; Zolkind PA; Matthew SM; Grin'kina N; Orynbayeva Z; Shaikh MF; Adler V; Michl J; Sarafraz-Yazdi E; Pincus MR; Bowne WB
Ann Clin Lab Sci; 2014; 44(3):241-8. PubMed ID: 25117093
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics.
Gaspar D; Freire JM; Pacheco TR; Barata JT; Castanho MA
Biochim Biophys Acta; 2015 Feb; 1853(2):308-16. PubMed ID: 25447543
[TBL] [Abstract][Full Text] [Related]
32. Preclinical Evidence on the Anticancer Properties of Food Peptides.
Rajendran SR; Ejike CE; Gong M; Hannah W; Udenigwe CC
Protein Pept Lett; 2017; 24(2):126-136. PubMed ID: 27538700
[TBL] [Abstract][Full Text] [Related]
33. The development of peptide-drug conjugates (PDCs) strategies for paclitaxel.
Wang L; Chen H; Wang F; Zhang X
Expert Opin Drug Deliv; 2022 Feb; 19(2):147-161. PubMed ID: 35130795
[TBL] [Abstract][Full Text] [Related]
34. Improving the efficacy of peptide vaccines in cancer immunotherapy.
Zahedipour F; Jamialahmadi K; Zamani P; Reza Jaafari M
Int Immunopharmacol; 2023 Oct; 123():110721. PubMed ID: 37543011
[TBL] [Abstract][Full Text] [Related]
35. Bacteria and bacterial anticancer agents as a promising alternative for cancer therapeutics.
Baindara P; Mandal SM
Biochimie; 2020 Oct; 177():164-189. PubMed ID: 32827604
[TBL] [Abstract][Full Text] [Related]
36. Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.
Dennison SR; Whittaker M; Harris F; Phoenix DA
Curr Protein Pept Sci; 2006 Dec; 7(6):487-99. PubMed ID: 17168782
[TBL] [Abstract][Full Text] [Related]
37. A Global Review on Short Peptides: Frontiers and Perspectives.
Apostolopoulos V; Bojarska J; Chai TT; Elnagdy S; Kaczmarek K; Matsoukas J; New R; Parang K; Lopez OP; Parhiz H; Perera CO; Pickholz M; Remko M; Saviano M; Skwarczynski M; Tang Y; Wolf WM; Yoshiya T; Zabrocki J; Zielenkiewicz P; AlKhazindar M; Barriga V; Kelaidonis K; Sarasia EM; Toth I
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467522
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
[TBL] [Abstract][Full Text] [Related]
39. Rational Design of Self-Assembled Mitochondria-Targeting Lytic Peptide Conjugates with Enhanced Tumor Selectivity.
Liu S; Wang B; Sheng Y; Dong S; Liu G
Chemistry; 2022 Jan; 28(3):e202103517. PubMed ID: 34791722
[TBL] [Abstract][Full Text] [Related]
40. Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications.
Chinnadurai RK; Khan N; Meghwanshi GK; Ponne S; Althobiti M; Kumar R
Biomed Pharmacother; 2023 Aug; 164():114996. PubMed ID: 37311281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
